Navigation Links
comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
Date:10/15/2009

RESTON, Va., Oct. 15 /PRNewswire-FirstCall/ -- comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released results from its third annual study Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry, which found that exposure to online media, including a brand's website and online ads, had a significant positive lift on a treatment's awareness and favorability. The results also showed that visitation to a brand's website generated significant levels of incremental new patient starts and refills. The study, performed in conjunction with pharmaceutical marketing consultancy Evolution Road, LLC, is designed to help pharmaceutical marketers better assess the success of their online marketing activities.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080115/COMSCORELOGO)

The study evaluated the impact of various online marketing activities including banner ads, rich media, search marketing and visits to a brand website on a pharmaceutical brand's awareness, favorability and sales results among both patients and prospects. The study was based on comScore's one million person U.S. panel, for which online activity is passively observed, and survey data collected throughout the past several years.

Branded Websites Play a Critical Role in Pharmaceutical Marketing

The study found that branded websites were the most effective form of online pharmaceutical marketing, with existing patients increasing their refill rate nearly 25 percentage points compared to those who did not visit the site. Patients who were new to a treatment increased an incremental 11.9 percentage points higher than the control. Exposure and interaction with rich media advertisements also improved refill rate among existing patients with a 14.0-point lift versus the control group.

    Incremental Effect on New Patient Starts and Adherence/Next
     Fill vs. Control
    Source: Online Marketing Effectiveness Benchmarks for the
     Pharmaceutical Industry (2009 Release)
    -----------------------------------------------------------
                                   Prospects          Patients
                                   ---------          --------
                              New Patient Starts   Adherence/Next Fill

                             -------------------   -------------------
    Exposed & Interacted
     (Rich Media*)              Not Reportable         +14.0 % points
    --------------------        --------------       ----------------
    Visited Brand.com            +11.9 % points       +24.7 % points
    -----------------            --------------       --------------

    * defined as interactive digital media

"A brand's website is the most effective online tactic for pharmaceutical marketers. Not only does it provide visitors with critically important information on the condition, treatment options and the drug itself, but it is also one of the few environments where a brand can build a dynamic and recurring relationship with its patients," said John Mangano, vice president of comScore marketing solutions. "It is important though to realize that a brand's website is only one critical piece of a comprehensive marketing campaign that includes online display ads, search marketing and offline marketing working in unison to raise awareness, educate consumers and ultimately drive conversion."

Online Advertising Causes Increases in Brand Awareness and Favorability

The study also found that online advertising and branded websites had a significant positive impact on awareness and favorability among patients and prospects. For prospects, exposure-only to an ad increased both aided and unaided brand awareness, with increases of 4.1 and 4.2 percentage points, respectively. Pharma websites played the greatest role in increasing awareness and favorability among patients and prospects. Prospects exhibited an 18.0-percentage point lift in favorability after visiting a branded website, while patients reported a 17.2-percentage point lift.

    Incremental Effect on Brand Awareness and Favorability Over Control Among
     Prospects and Patients
    Source: Online Marketing Effectiveness Benchmarks for the Pharmaceutical
     Industry
     (2009 Release)
    -------------------------------------------------------------------------
                                           Prospects               Patients
                                           ---------               --------
                               Aided     Unaided
                               Brand      Brand        Brand        Brand
    Marketing Activity       Awareness  Awareness  Favorability  Favorability
    ------------------       ---------  ---------  ------------  ------------
    Exposure-Only to Online                                           Not
     Ads                           4.1        4.2          13.2   Reportable
    -----------------------        ---        ---          ----   ------------
    Exposure to and
     Interaction with
     Online Ads (Rich
     Media*)                       2.2        5.4           1.9            5.5
    -----------------              ---        ---           ---            ---
    Visited Brand.com             11.8       17.1          18.0           17.2
    -----------------             ----       ----          ----           ----

    * defined as interactive digital media

To request a copy of the study Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry (2009 Release) or for more information on comScore Pharmaceutical and Healthcare Solutions, please visit: http://www.comscore.com/Press_Events/Presentations_Whitepapers/2009/Online_Marketing_Effectiveness_Benchmarks_for_the_Pharmaceutical_Industry

About comScore Pharmaceutical and Healthcare Solutions

comScore Pharmaceutical and Healthcare Solutions delivers in-depth information needed to understand the impact that brand, condition-specific, and health websites have on consumers' brand awareness, conversion, and patient compliance. comScore's products deliver actionable insight to help refine consumer profiles, identify key alliances, optimize interactive marketing initiatives, benchmark against the competition and accurately measure the ROI of Web site and online marketing programs.

About comScore

comScore, Inc. (NASDAQ: SCOR) is a global leader in measuring the digital world and preferred source of digital marketing intelligence. For more information, please visit www.comscore.com/companyinfo.

About Evolution Road

Evolution Road is a marketing innovation consultancy focused on helping brands leverage digital channels to drive their business. Evolution Road believes that the Internet will dramatically improve how pharmaceutical brands are marketed for the benefit of consumers, physicians and pharmaceutical brands. For more information, please contact Paul Ivans at pivans@evolutionroad.com, or visit www.evolutionroad.com.

Follow us on Twitter

http://twitter.com/comScore

http://twitter.com/gfulgoni

http://twitter.com/m_abraham

SOURCE comScore, Inc.


'/>"/>
SOURCE comScore, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures, According to comScore
2. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
3. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
4. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
5. DATATRAK Signs 6 Year Study with New Device Client
6. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
7. Bundling Two Generic Low-Cost Heart Drugs Prevents Heart Attack and Stroke in Large, Diverse Population, Observational Clinical Study Shows
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
10. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
11. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):